Clinical Trial Update: A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial of omalizumab (Xolair) in work-related animal-induced allergy-induced asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy Induced Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Bernstein Clinical Research Center | Conditions: Allergy Induced Asthma | Phase 4 | Status: WITHDRAWN